|Bid||177.01 x 300|
|Ask||177.75 x 300|
|Day's Range||177.00 - 178.89|
|52 Week Range||132.39 - 178.89|
|PE Ratio (TTM)||22.72|
|Dividend & Yield||2.50 (1.40%)|
|1y Target Est||N/A|
With its $249 test to screen for 30 genes linked to eight hereditary cancers, Color Genomics Inc. has pushed to detect cancer earlier but also take price away as a barrier. Color took a big step toward those goals Monday: It said a number of health insurers — including UnitedHealthcare, part of UnitedHealth Group Inc. (UNH), Anthem Inc. (ANTM) and Blue Shield of California — will contract starting June 15 for its saliva test for cancer. An agreement by an insurance company to cover a product is scientific validation of the technology, since insurers tend to do rigorous background checks on drugs, devices or tests before agreeing to pay for them.
UnitedHealth Group, Inc.???s (UNH) information and technology-enabled health services business "Optum" recently announced its collaboration with Merck & Co. Inc (MRK).
Interest Coverage Ratio is used to determine how effectively a company can pay the interest charges on its debt.